Top Stories News
Top Stories news
-
News Education can encourage patient involvement in clinical trials, presentation to say
Education can help to allay patients' concerns over participating in clinical trials -
News Researchers get closer to universal flu jab
Scientists are a step closer to a universal flu vaccine -
News Class of pharmaceuticals appear to prevent and treat Alzheimer's
A class of pharmaceuticals seem to prevent Alzheimer's disease -
News Researchers discover biomarkers for IBD
US scientists have discovered certain biomarkers for IBD -
News Monoclonal antibody appears to alleviate symptoms of asthma
Phase IIa clinical trial suggests asthma treatment may be effective -
News Newtricious appoints first supervisory board
Natural ingredients specialised nutrition company Newtricious has appointed its first supervisory board. -
News NAMENDA XR drug approved by FDA
The Alzheimer's disease drug is now available in US pharmacies. -
News New chemo drug may be more effective in certain patient groups
A phase three clinical trial of eribulin mesylate suggested it may be the optimal treatment in certain patient populations. -
News Pain management drugs market boasts significant growth
The subsector experienced growth of three per cent between 2010 and 2012. -
News Possible drug pathway for heart failure identified
High levels of the G6P metabolite could disrupt pump function and cause heart failure. -
News $89 Billion in Branded Prescription Sales at Risk for Generic Competition By 2014
Generic drugs account for more than 70% of prescriptions dispensed in the U.S. and that figure is expected to grow as brand drugs come off patent and face generic competition. -
News Improving blood transfusions 'could be massive'
Researchers have developed a new approach to restoring nitric oxide to blood, paving the way for significant developments. -
News Iroko Pharmaceuticals withdraws initial public offering
Iroko Pharma has announced that it will withdraw its initial public offering. -
News $1bn Pharmaceutical Deal Halted in Egypt
A one billion dollar pharmaceutical deal in the Middle East has been jeopardised by anti-government protests in the region. -
News Wockhardt receives approval for generic epilepsy tablets
Approval has been granted for Wockhardt to market generic Lamotrigine tablets in various dosages. -
News Roche to make clinical trial data more accessible
Roche has announced a new process for making its clinical trial data more transparent. -
News Clinical trial suggests type 1 diabetes cure is near
Scientists are confident that they are making progress in the treatment for type 1 diabetes, developing a new vaccine that effectively shuts down the immune system. -
News Funding granted for DMD therapy development
The UK Biomedical Catalyst Fund has granted £2.4 million funding for the development of DMD treatment. -
News UK licence granted to new prostate cancer drug
XTANDI is a treatment option for prostate cancer patients who are resistant to first-line therapy. -
News AD simulation tool may improve clinical trial design
The computer model should facilitate the design of superior AD clinical trials. -
News UK may regain status as world leader in clinical research
Clinical research experts believe that employers should take a more broad-minded approach to recruitment. -
News Cancer risk could be cut by removing fallopian tubes
Operating to remove the fallopian tubes could cut the risk of ovarian cancer. -
News Cyanotech announces third quarter takings
Success for health product specialist Cyanotech in the third quarter of fiscal 2013. -
News Positive results for revolutionary cancer drug in human clinical trial
The drug prevents tumour growth through inhibition of HSP90. -
News Study suggests hTee can improve patient management
The unique hTee technology can aid patient management for those undergoing heart surgery. -
News Oncologists struggling with chemotherapy drug shortages
Oncologists may omit vital chemotherapy doses when supplies are low. -
News New antibiotic '100-times more effective at treating TB'
The KKL-35 antibiotic could treat anthrax and tuberculosis by disrupting trans-translation. -
News Fat triggers rheumatoid arthritis, scientists discover
Fat has been shown to trigger rheumatoid arthritis -
News Antioxidants do not help women conceive
Despite previous clinical trials suggesting that antioxidants can help women conceive, a new review says that this is not enough. Women who undergo fertility treatment are often encouraged to take dietary supplements that contain antioxidants. Yet th... -
News Immunisation strategies for dengue fever improving
New data is helping improve immunisation strategies in the treatment of dengue fever. -
News Popular epilepsy drug hits UK market in liquid form
A common treatment for epilepsy has been launched in the UK in liquid form -
News Scientists a step closer to new treatments for breast and melanoma cancers
Scientists have discovered how to manipulate a mutant protein to kill cancer -
News Scientists make T cell discovery that could improve stem cell transplant process
A breakthrough on how T cells operate after stem cell transplants could lead to improvements in the process -
News Valvuplasty balloon catheter receives 510(k) clearance in the US
A figure-8 valvuplasty balloon catheter has received 510(k) clearance in the US -
News Achaogen signs $60m contract to launch Phase 3 drug trails
US pharma firm Achaogen has signed a new deal to push forward its research into plazomicin. -
News Scientists discover synthetic vitamin D could combat liver fibrosis
A synthetic form of vitamin D could be used to prevent the progression of liver fibrosis. -
News US research hints at new methods for identifying colorectal cancer
A study from the US has identified potential methods for detecting colorectal cancer. -
News Report pinpoints Midwest as bioscience powerhouse of the US
A new report from Ernst & Young has named the Midwest as Americas leading region for bioscience research. -
News New tool for live cell imaging launched
A new toll has been launched for live cell imaging. -
News Xplore and Novatek collaborate on mobile data device for pharmaceuticals
A new tablet device has been developed for the pharmaceutical industry. -
News Herpes treatment gets market authorisation from US regulator
A herpes treatment has been given market authorisation by the US FDA. -
News Phase 2 study shows potential for sickle cell disease treatment
A phase 2 study has shown promise for a new treatment aimed at sickle cell disease patients. -
News FDA to review NDA for the treatment of autosomal dominant polycystic kidney...
Tolvaptan is being reviewed as a potential treatment for ADPKD. -
News Genistein could prove beneficial for the treatment of colorectal cancer
A natural soy-based compound could be used for the treatment of colorectal cancer. -
News ES414 could be therapeutic for castrate-resistant prostate cancer
A new molecule is being developed as a therapeutic for prostate cancer. -
News Researchers uncover potential alternative to statins
An alternative treatment to statins could be on the horizon. -
News Clinical trial locator goes live
New website to help potential trial participants locate their closest trial. -
News Icon acquires new businesses for its FSP business
Icon has acquired Cross County Healthcare's Clinical Trial Services Division. -
News Tengion gets green light for Sweden trial
Revolutionary kidney augment trial gets green light. -
News Clinical trials highlight efficacy of curcumin for postmenopause
New research suggests curcumin can help prevent arterial stiffness, a major risk factor for heart disease in postmenopausal women. -
News Israeli pharma firm to trial new oral migraine treatment
RedHill BioPharma of Israel is to start work on testing its new migraine treatment in the US. -
News English pharmaceutical company wins new £5 cash injection
England's Oxford Pharmascience has secured fresh funding for its research and development efforts. -
News Biopharmaceutical clinical trials boost Texas economy
The industry helps to support the economy in Texas. -
News Theraclone Sciences secures funding
Antibody development company announces project funding. -
News New HIV-1 drug approved
EU to get new drug for treating HIV-1 infection. -
News US authorities accept patent for TECFIDERA
Officials in the US have given their approval to the patent. -
News Expert reveals fall of clinical trials in Europe
Meir Pugatch explained that Europe has a low level of clinical trials activity. -
News Pharma companies discuss role of IT in the industry
IT is helping scientists to spend more money on actual lab work. -
News AstraZeneca to invest in boosting research and development prowess
AstraZeneca will invest in several of its existing research and development centres around the world. -
News Breast cancer drug given regulatory green light
A new drug to treat HER2-positive breast cancer has received regulatory approval in the UK. -
News New drug formulations to be cheaper thanks to research efficiency
The pharmaceutical industry could benefit by developing new drug formulations that are cheaper than existing remedies. -
News UK to change patent laws to attract clinical trials
The UK government intends to take steps to attract drug research and development projects back to the UK. -
News Apposition III clinical trials show low mortality rates
The Stentys Self-Apposing Stent clinical trials show low death rates in patients following severe heart attack. -
News Drug formulation developer Dyax announces board changes
The executive vice president chief operating officer of the company, which specialises in drug formulations for unmet medical needs, is leaving for other opportunities. -
News Rheumatoid arthritis clinical trial to continue
Drug formulation PRTX-100 passed a scheduled interim data safety monitoring committee meeting. -
News OncoMed begins Phase 1 clinical trial of stem cell drug
OMP-52M51 is a therapeutic that targets cancer stem cells. -
News Immune system-enhancing drug could beat colorectal cancer
Tests involving the delivery of an immune system-enhancing drug to patients suffering from colorectal cancer have shown promise. -
News Abbott completes separation into two independent companies
A new independent company called AbbVie has been formed to take forward Abbott's research-based pharmaceuticals business. -
News Saudi Arabia pharma market to reach $4.7bn by 2016
Saudi Arabia is one of the largest pharmaceutical markets in the Middle East and is due to experience steady growth. -
News Novartis names Dr Joerg Reinhardt as new chairman
Dr Joerg Reinhardt will be the new chairman of Novartis, succeeding Dr Daniel Vasella. -
News OvaSciences announced 2012 financial results
OvaSciences enjoyed a strong year with most of its R&D spend coming on CROs for a major new trial. -
News Ligand receives milestone payment in development of RE-021
Development of the clinical candidate RE-021 is being handled by Retrophin, which also has commercialisation rights. -
News Digital Pharma Experience set for Prague
The Digital Pharma Experience takes place in Prague in May. -
News Diagnovus designs assay for DLBCL
Diagnovus' new gene expression assay aims to provide more accurate risk profiles for DLBCL patients. -
News Roche to commercialise Chiasmas Octreolin treatment
Roche has acquired global licencing rights for the acromegaly treatment, which is in phase three trials. -
News Almac and DSM Pharma sharing enzyme expertise
The two firms are collaborating to improve their green performance and enzyme process development. -
News Nerve growth trial goes international
Neurotrophic keratitis patients to get eyedrop treatment. -
News Ulcerative colitis patients get new treatment
New treatment to help mild sufferers of ulcerative colitis. -
News Cancer Commons announces expansion
Cancer research organisation will include six new members. -
News New contract services provided by BioMed
BioMed has launched its new pharmacy management system RxVector. -
News Heart failure treatment gets funding
New diagnostic tests to be developed as a result of funding. -
News Microarray to be used in human identification
Affymetrix and DNA Link team up to consumerise DNA identification technology . -
News Genentech sees positive results from its CLL drug trials
Genentech has seen positive results in Phase III trials of its CLL drug. -
News Vertex sets out goals for 2013
Vertex will continue with its research into cystic fibrosis, hepatitis C and autoimmune diseases this year. -
News Development of sealants will speed up move away from conventional sutures
New innovations in the medical adhesives sector will accelerate the move away from the use of sutures and staples. -
News TetraLogic receives birinapant patent
Japan recognises birinapant innovation. -
News Sectra enters Southeast Asian market
Asia to get new visualisation technology from Sectra. -
News Leading pharmaceutical companies set to merge
BioSante and ANI Pharmaceuticals arrange special meetings for merger. -
News New fund to benefit pancreatic cancer research
US foundation commits £25 million to fighting pancreatic cancer. -
News Avoca Group announces key initiatives for outsourcing consortium
Avoca's outsourcing group has set out its key goals for 2013. -
News Skin substitute trials 'a success'
Patients will no longer have to undergo painful autografting for second-degree burns. -
News BioChemics patents wound healing treatment
BioChemics ventures into wound treating market. -
News Top pharmacists gather for conference
Independent pharmaceutical companies to discuss the changing industry. -
News Anacor director receives science award
Scientific medal goes to Dr Lucy Shapiro of Anacor Pharmaceuticals. -
News Spectrum Pharmaceuticals outlines five-year vision
Spectrum announces new arrival plus its plan for the next five years. -
News Outsourcing market to value $41bn
Device outsourcing set to rise exponentially between now and 2018. -
News Pharmaceutical companies increase outsourcing
Number of pharmaceutical companies using outsourcing increases. -
News South Korea set for global biosimilars leadership
A Frost & Sullivan report has predicted significant growth in the South Korean biosimilars market between now and 2020. -
News Brain tumour investment 'lagging'
Funding for research and treatment of brain tumours is 'lagging behind' other cancers, says a charity. -
News Pfizer Licenses Quinazoline Drug Program
Repligen Corp. has entered into an exclusive worldwide licensing agreement with Pfizer to advance its spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA (FSMA). -
News Tranzyme, BMS Complete Drug Pact
Tranzyme Pharma has successfully completed its chemistry-based drug discovery collaboration with Bristol-Myers Squibb and has transferred compounds, across multiple drug targets, to BMS for further development. -
News Israeli pharma market 'worth $2.3 billion by 2020'
GlobalData's latest report looks at the prospects for the pharmaceutical industry in Israel. -
News Chinese pharmaceutical market to enjoy 'dramatic' growth
A new report looks at the potential for growth in the Chinese pharmaceutical market. -
News GSK forms partnership with Vodafone to help increase childhood vaccination in Mozambique
GSK has formed a partnership with Vodafone to harness innovative mobile technology to help vaccinate more children against common infectious diseases in Africa. -
News Epilepsy drug market to reach nearly $3.7bn by 2016
Decision Resources has published its latest predictions for the epilepsy drug market through 2021. -
News Next Generation Sequencing of GATC Biotech AG Accredited by German DAkkS
GATC Biotech customers can expect highest quality standards for Next Generation Sequencing projects from official accreditation -
News Health economics and outcomes research 'increasingly important to pharma'
A new report suggests that more and more pharmaceutical companies are devoting dedicated budgets to health economics and outcomes research. -
News Ranbaxy Begins Atorvastatin Recall
Ranbaxy, Inc., a subsidiary of Indias Ranbaxy Laboratories Ltd., has initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium tablets (10 mg, 20 mg and 40 mg), a generic of Pfizers Lipitor. -
News Schott to expand pharmaceutical packaging manufacturing in Russia
German company Schott has announced plans to increase its production capacity in Russia by more than 50 per cent. -
News Aspireo Receives Positive Opinion from EMA for Orphan Disease Designation for Somatoprim
Aspireo Receives Positive Opinion from EMA for Orphan Disease Designation for Somatoprim -
News GSK set to increase stake in Indian subsidiary
GSK has offered to increase its stake in GSK Consumer Healthcare in India. -
News AstraZeneca Canada and Pfizer Canada partner with Quebec government
The NEOMED Institute is a new public-private partnership between biopharmaceutical companies and the Quebec government. -
News Number of temperature-sensitive drugs 'set to increase'
A growing number of biopharmaceutical products have cold chain requirements, according to IMARC Group's latest report. -
News Pharma industry to thrive after 2020
A new report by PwC has highlighted the challenges faced by pharmaceutical companies if they are to succeed beyond 2020. -
News Global diabetes drugs market set for 9.7pc annual growth
TechNavio's latest report looks at the potential for growth in the diabetes drugs market. -
News DBT waiting for nod to set up 2 advanced institutes for research at cost of Rs.600 cr
The Department of Biotechnology (DBT) is planning to set up two advanced institutes for research including an Institute of Chronic Disease and Biotechnology. -
News Commerce minister's intervention sought to stop enforcing barcodes on pharma exports
The Medicines and Healthcare Products Agency (MHRA) is having consultations with the pharma industry and clinical research organisations (CROs) about the European Commissions proposal to have a new clinical trials regulation. -
News Definiens Appoints Dr. Gerald Möller as Chairman of its Supervisory Board
Definiens AG, the leader in image analysis for Digital Pathology, today announced that Dr. Gerald Möller, has joined the company's supervisory board as an independent member and has been appointed chairman.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance